Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
CVS Health to invest $12.4M in affordable housing in south Phoenix » 08:10
03/04/21
03/04
08:10
03/04/21
08:10
CVS

CVS Health

$69.03 /

+0.12 (+0.17%)

CVS Health announced it…

CVS Health announced it will invest $12.4M to build 60 new units of affordable housing in south Phoenix and expand the company's no-cost preventive health screening program, Project Health, in the greater Phoenix area as part of CVS Health's commitment to provide $600M over five years to address racial inequity and social determinants of health in Black communities.

ShowHide Related Items >><<
CVS CVS Health
$69.03 /

+0.12 (+0.17%)

CVS CVS Health
$69.03 /

+0.12 (+0.17%)

03/02/21 Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
CVS CVS Health
$69.03 /

+0.12 (+0.17%)

CVS CVS Health
$69.03 /

+0.12 (+0.17%)

CVS CVS Health
$69.03 /

+0.12 (+0.17%)

CVS CVS Health
$69.03 /

+0.12 (+0.17%)

Wednesday
Conference/Events
IntercontinentalExchange holds a conference call with CVS Caremark » 10:17
03/03/21
03/03
10:17
03/03/21
10:17
CVS

CVS Health

$68.57 /

-0.34 (-0.49%)

, ICE

IntercontinentalExchange

$112.53 /

-1.11 (-0.98%)

Dr. Sree Chaguturu, CVS…

Dr. Sree Chaguturu, CVS Health & Chief Medical Officer of CVS Caremark, provides an update on COVID-19 variants and the supply and distribution of vaccines on a conference call to be held on March 3 at 12 pm hosted by Intercontinental Exchange.

ShowHide Related Items >><<
ICE IntercontinentalExchange
$112.53 /

-1.11 (-0.98%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

03/02/21 Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
ICE IntercontinentalExchange
$112.53 /

-1.11 (-0.98%)

01/12/21 Barclays
IntercontinentalExchange price target raised to $134 from $125 at Barclays
01/07/21 Piper Sandler
IntercontinentalExchange price target raised to $127 from $117 at Piper Sandler
12/22/20 Compass Point
IntercontinentalExchange price target raised to $125 from $110 at Compass Point
12/18/20 Raymond James
IntercontinentalExchange price target raised to $131 from $125 at Raymond James
ICE IntercontinentalExchange
$112.53 /

-1.11 (-0.98%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

  • 05
    Nov
  • 10
    Sep
ICE IntercontinentalExchange
$112.53 /

-1.11 (-0.98%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

ICE IntercontinentalExchange
$112.53 /

-1.11 (-0.98%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

CVS CVS Health
$68.57 /

-0.34 (-0.49%)

Recommendations
Cigna acquisition 'incremental negative' for Hims & Hers, says Piper Sandler » 04:50
03/03/21
03/03
04:50
03/03/21
04:50
HIMS

Hims & Hers

$16.00 /

+0.74 (+4.85%)

, CI

Cigna

$219.43 /

+4.71 (+2.19%)

, TDOC

Teladoc

$217.68 /

-5.62 (-2.52%)

, AMWL

Amwell

$24.58 /

-0.4 (-1.60%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland views Cigna's (CI) announced plans to acquire MDLIVE as an "incremental negative" for Hims & Hers (HIMS). MDLIVE may be sold as a service to Amazon Pharmacy (AMZN) to enable telehealth and pharmaceutical fulfillment, which would be directly competitive with Hims & Hers, Wieland tells investors in a research note. The analyst views the prospect of an Amazon Pharmacy offering with integrated MDLIVE telehealth as incrementally negative for Hims. While MDLIVE takes insurance and often costs the consumer $0 for a telehealth visit that begins within 15 minutes of a request, Hims & Hers' "nascent" primary care offering promises a visit within 24 hours for the non-zero cost of $39 cash, a competitive disadvantage, says Wieland. The analyst also views the Cigna deal as an "incremental positive" for Teladoc (TDOC) and Amwell (AMWL).

ShowHide Related Items >><<
TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

HIMS Hims & Hers
$16.00 /

+0.74 (+4.85%)

CI Cigna
$219.43 /

+4.71 (+2.19%)

AMWL Amwell
$24.58 /

-0.4 (-1.60%)

HIMS Hims & Hers
$16.00 /

+0.74 (+4.85%)

03/02/21 Citi
Hims & Hers upgraded to Buy from Neutral at Citi
03/02/21 Citi
Hims & Hers upgraded to Buy from Neutral at Citi
02/17/21 Citi
Hims & Hers initiated with a Neutral at Citi
02/12/21
Fly Intel: Top five analyst initiations
CI Cigna
$219.43 /

+4.71 (+2.19%)

02/05/21 Deutsche Bank
Cigna price target lowered to $270 from $280 at Deutsche Bank
02/05/21 Citi
Cigna undervalued after 'excessive' selloff, says Citi
02/01/21 BofA
US 1 List changes at BofA
01/07/21 Stephens
Cigna announced 'competitive' dividend 'at long last,' says Stephens
TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

02/25/21 Stifel
Teladoc price target lowered to $234 from $270 at Stifel
02/25/21 KeyBanc
Teladoc price target raised to $270 from $245 at KeyBanc
02/25/21 Canaccord
Teladoc weakness a buying opportunity, says Canaccord
02/25/21 DA Davidson
Teladoc price target raised to $275 from $260 at DA Davidson
AMWL Amwell
$24.58 /

-0.4 (-1.60%)

02/22/21 Piper Sandler
Amwell price target raised to $45 from $44 at Piper Sandler
01/27/21 Credit Suisse
Amwell downgraded to Neutral from Outperform at Credit Suisse
01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

CI Cigna
$219.43 /

+4.71 (+2.19%)

AMWL Amwell
$24.58 /

-0.4 (-1.60%)

  • 15
    Jan
  • 17
    Sep
TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

HIMS Hims & Hers
$16.00 /

+0.74 (+4.85%)

CI Cigna
$219.43 /

+4.71 (+2.19%)

TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

CI Cigna
$219.43 /

+4.71 (+2.19%)

AMWL Amwell
$24.58 /

-0.4 (-1.60%)

TDOC Teladoc
$217.68 /

-5.62 (-2.52%)

HIMS Hims & Hers
$16.00 /

+0.74 (+4.85%)

CI Cigna
$219.43 /

+4.71 (+2.19%)

AMWL Amwell
$24.58 /

-0.4 (-1.60%)

Tuesday
Recommendations
1Life selloff on congressional inquiry overdone, says Citi » 16:07
03/02/21
03/02
16:07
03/02/21
16:07
ONEM

1Life Healthcare

$45.81 /

-2.97 (-6.09%)

The selloff in 1Life…

The selloff in 1Life Healthcare today on news of a congressional inquiry into its vaccine distribution processes is overdone, Citi analyst Daniel Grosslight tells investors in a research note. The analyst says that while any inequitable distribution of the COVID-19 vaccine is concerning, he does not think there was "anything nefarious in what appears to be a distribution process that relied too heavily on patient attestation." Grosslight thinks 1Life will continue to play an important role in the vaccine distribution. With that said, he notes that the company is assuming less than $2M of revenue from vaccine distribution in its current guidance. Grosslight keeps a Buy rating on 1Life Healthcare with a $61 price target. The stock closed Tuesday down 6% to $46.01.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

03/01/21 Credit Suisse
1Life Healthcare price target raised to $56 from $40 at Credit Suisse
02/26/21 Truist
1Life Healthcare price target raised to $56 from $40 at Truist
02/26/21 Deutsche Bank
1Life Healthcare price target raised to $53 from $42 at Deutsche Bank
02/04/21 Citi
1Life Healthcare price target raised to $62 from $42 at Citi
ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

ONEM 1Life Healthcare
$45.81 /

-2.97 (-6.09%)

Periodicals
IPG Mediabrands planning event focused on Black-owned media firms, AdAge says » 15:37
03/02/21
03/02
15:37
03/02/21
15:37
IPG

Interpublic Group

$26.97 /

+0.16 (+0.60%)

, UONE

Urban One

$5.67 /

-0.02 (-0.35%)

, AXP

American Express

$139.37 /

+0.66 (+0.48%)

, BMWYY

BMW

$0.00 /

+ (+0.00%)

, CVS

CVS Health

$69.09 /

-0.19 (-0.27%)

, JNJ

Johnson & Johnson

$159.29 /

-0.04 (-0.03%)

IPG Mediabrands, a…

IPG Mediabrands, a division of Interpublic Group of Companies (IPG), intends to gather awareness and move money to Black-owned and -focused media businesses with a week-long event highlighting such firms, AdAge's Jeanine Poggi reports. IPG's Equity Upfront plans to highlight linear, streaming, digital, radio and print brands such as Allen Media Group/Entertainment Studios, BET Network, Essence Communications and Urban One (UONE), as well as others, the author notes. Such media companies would get the change to make pitches to Mediabrands clients, including American Express (AXP), BMW (BMWYY), CVS Health (CVS), Johnson & Johnson (JNJ), and others, the author says. Reference Link

ShowHide Related Items >><<
UONE Urban One
$5.67 /

-0.02 (-0.35%)

JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

IPG Interpublic Group
$26.97 /

+0.16 (+0.60%)

CVS CVS Health
$69.09 /

-0.19 (-0.27%)

BMWYY BMW
$0.00 /

+ (+0.00%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

IPG Interpublic Group
$26.97 /

+0.16 (+0.60%)

02/19/21 BMO Capital
Interpublic Group price target raised to $28 from $23 at BMO Capital
12/15/20 Citi
Interpublic Group price target raised to $29 from $24 at Citi
12/11/20 Barclays
Interpublic Group initiated with an Overweight at Barclays
10/27/20 Citi
Interpublic Group price target raised to $24 from $22 at Citi
UONE Urban One
$5.67 /

-0.02 (-0.35%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Baird
American Express downgraded at Baird, shares fairly valued here
02/16/21 Baird
American Express downgraded to Neutral from Outperform at Baird
01/28/21 DZ Bank
American Express upgraded to Buy from Hold at DZ Bank
BMWYY BMW
$0.00 /

+ (+0.00%)

02/22/21 Argus
Livent upgraded to Buy from Hold at Argus
02/03/21 Oddo BHF
BMW downgraded to Underperform from Neutral at Oddo BHF
01/26/21 UBS
BMW price target raised to EUR 71 from EUR 65 at UBS
01/07/21 Deutsche Bank
BMW downgraded to Hold from Buy at Deutsche Bank
CVS CVS Health
$69.09 /

-0.19 (-0.27%)

03/02/21 Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

IPG Interpublic Group
$26.97 /

+0.16 (+0.60%)

CVS CVS Health
$69.09 /

-0.19 (-0.27%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

UONE Urban One
$5.67 /

-0.02 (-0.35%)

JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

IPG Interpublic Group
$26.97 /

+0.16 (+0.60%)

CVS CVS Health
$69.09 /

-0.19 (-0.27%)

BMWYY BMW
$0.00 /

+ (+0.00%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

IPG Interpublic Group
$26.97 /

+0.16 (+0.60%)

CVS CVS Health
$69.09 /

-0.19 (-0.27%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

JNJ Johnson & Johnson
$159.29 /

-0.04 (-0.03%)

CVS CVS Health
$69.09 /

-0.19 (-0.27%)

AXP American Express
$139.37 /

+0.66 (+0.48%)

Hot Stocks
House committee seeks documents from 1Life over vaccine practices » 11:18
03/02/21
03/02
11:18
03/02/21
11:18
ONEM

1Life Healthcare

$47.83 /

-0.95 (-1.95%)

Representative James…

Representative James Clyburn, chairman of the House Select Subcommittee on the Coronavirus Crisis, sent a letter yesterday to 1Life Healthcare CEO Amir Dan Rubin seeking documents on the company's vaccine allocation practices. The letter states in part: "Prioritizing the vaccination of Americans who are at higher risk from the coronavirus is critical to saving lives and controlling the pandemic as vaccine manufacturing and distribution ramp up. Yet reports indicate that One Medical has repeatedly and intentionally disregarded vaccine eligibility requirements in multiple cities and states over the past two months-diverting vital vaccine doses away from vulnerable populations to benefit wealthy concierge clients and friends and family members of your company's executives who are not eligible under state and local guidelines. Despite being warned that the company's lax oversight of vaccine eligibility rules was allowing ineligible patients to jump the line, One Medical has reportedly failed to promptly implement an effective protocol to verify eligibility and instructed staff not to police eligibility. As a result of these irresponsible practices, numerous authorities have now halted distributions of vaccine doses to the company. I write today to seek documents and information on One Medical's vaccination practices and to urge you to comply with state and local prioritization guidelines." Reference Link

ShowHide Related Items >><<
ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

03/01/21 Credit Suisse
1Life Healthcare price target raised to $56 from $40 at Credit Suisse
02/26/21 Truist
1Life Healthcare price target raised to $56 from $40 at Truist
02/26/21 Deutsche Bank
1Life Healthcare price target raised to $53 from $42 at Deutsche Bank
02/04/21 Citi
1Life Healthcare price target raised to $62 from $42 at Citi
ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

ONEM 1Life Healthcare
$47.83 /

-0.95 (-1.95%)

Downgrade
Cowen downgrades Ontrak to Market Perform until visibility returns » 07:39
03/02/21
03/02
07:39
03/02/21
07:39
OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, CVS

CVS Health

$69.26 /

+1.13 (+1.66%)

As reported previously,…

As reported previously, Cowen analyst Charles Ryhee downgraded Ontrak to Market Perform from Outperform with a price target of $35, down from $75. The analyst expects the shares to be rangebound until visibility returns following the loss of its largest customer Aetna (CVS). He said execution needs to return and he has less confidence in implied revenue guidance given the limited visibility.

ShowHide Related Items >><<
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/02/21 Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
03/02/21 Canaccord
Ontrak downgraded to Hold from Buy at Canaccord
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
CVS CVS Health
$69.26 /

+1.13 (+1.66%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

Downgrade
Canaccord downgrades Ontrak after loss of largest customer » 07:28
03/02/21
03/02
07:28
03/02/21
07:28
OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, CVS

CVS Health

$69.26 /

+1.13 (+1.66%)

As reported previously,…

As reported previously, Canaccord analyst Richard Close downgraded Ontrak (OTRK) to Hold from Buy with a price target of $30, down from $89. The analyst said the impeding loss of its largest customer Aetna (CVS) was 64% of its revenue and it was expected to remain a growth contributor in 2021. Despite its loss, Close believes customer concentration risk remains but he said management has detailed a robust pipeline with expansions and new client logos and needs to execute successfully in order to justify any multiple expansion.

ShowHide Related Items >><<
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

03/02/21 Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
03/02/21 Canaccord
Ontrak downgraded to Hold from Buy at Canaccord
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
CVS CVS Health
$69.26 /

+1.13 (+1.66%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

Monday
On The Fly
Ontrak plunges after announcing loss of Aetna contract » 11:12
03/01/21
03/01
11:12
03/01/21
11:12
OTRK

Ontrak

$30.65 /

-28.48 (-48.17%)

, CVS

CVS Health

$69.19 /

+1.06 (+1.56%)

Shares of Ontrak (OTRK)…

ShowHide Related Items >><<
OTRK Ontrak
$30.65 /

-28.48 (-48.17%)

CVS CVS Health
$69.19 /

+1.06 (+1.56%)

OTRK Ontrak
$30.65 /

-28.48 (-48.17%)

03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
CVS CVS Health
$69.19 /

+1.06 (+1.56%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
OTRK Ontrak
$30.65 /

-28.48 (-48.17%)

CVS CVS Health
$69.19 /

+1.06 (+1.56%)

CVS CVS Health
$69.19 /

+1.06 (+1.56%)

OTRK Ontrak
$30.65 /

-28.48 (-48.17%)

CVS CVS Health
$69.19 /

+1.06 (+1.56%)

OTRK Ontrak
$30.65 /

-28.48 (-48.17%)

CVS CVS Health
$69.19 /

+1.06 (+1.56%)

Downgrade
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna » 10:21
03/01/21
03/01
10:21
03/01/21
10:21
OTRK

Ontrak

$32.45 /

-26.68 (-45.12%)

, CVS

CVS Health

$68.88 /

+0.75 (+1.10%)

As previously reported,…

As previously reported, RBC Capital analyst Sean Dodge downgraded Ontrak (OTRK) to Sector Perform from Outperform with a price target of $32, down from $82, arguing that the loss of Aetna, which is its largest client, "represents not only a significant headwind to revenue, but also to the growth outlook." As a result of the loss of its contract with CVS' (CVS) Aetna unit means management is now targeting 2021 revenue of $100M, or about 21% growth, down from the 100% growth it was preliminarily targeting, Dodge noted.

ShowHide Related Items >><<
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
11/18/20 B. Riley Securities
Ontrak initiated with a Buy at B. Riley Securities
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21
Fly Intel: Top five analyst upgrades
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.